β-Adrenergic and muscarinic cholinergic receptor densities in the human sinoatrial node: Identification of a high β2-adrenergic receptor density

Journal of Cardiovascular Electrophysiology

Volumn 7, Issue 11, 1996, Pages 1039-1049

  Rodefeld, Mark D ^a   Beau, Scott L ^a   Schuessler, Richard B ^a   Boineau, John P ^a   Saffitz, Jeffrey E ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

autonomic regulation; human sinoatrial node; muscarinic cholinergic receptors; radioligand autoradiography; adrenergic receptors

Indexed keywords

5 [2 [[2 HYDROXY 3 [4 (1 METHYL 4 TRIFLUOROMETHYL 2 IMIDAZOLYL)PHENOXY]PROPYL]AMINO]ETHOXY]SALICYLAMIDE; BETA ADRENERGIC RECEPTOR; CYANOIODOPINDOLOL; MUSCARINIC RECEPTOR; RECEPTOR SUBTYPE;

ADOLESCENT; ADULT; ARTICLE; AUTONOMIC INNERVATION; AUTORADIOGRAPHY; CHRONOTROPISM; CLINICAL PROTOCOL; EXTRACELLULAR MATRIX; FEMALE; HEART MUSCLE; HEART RATE; HEART RHYTHM; HUMAN; HUMAN TISSUE; LIGAND BINDING; MALE; PRIORITY JOURNAL; RECEPTOR DENSITY; SINUS NODE;

EID: 0029912839     PISSN: 10453873     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8167.1996.tb00479.x     Document Type: Article

References (56)

1. West TC, Falk G, Cervoni P: Drug alteration of trans-membrane potentials in atrial pacemaker cells. J Pharmacol Exp Ther 1956;117:245-252.
2. Sano T, Yamagishi S: Spread of excitation from the sinus node. Circ Res 1965;16:423-430.
3. Bouman LN, Gerlings ED, Biersteker PA, et al: Pacemaker shift in the sino-atrial node during vagal stimulation. Pflügers Arch 1968;302:255-267.
4. Goldberg JM: Intra-SA-nodal pacemaker shifts induced by autonomic nerve stimulation in the dog. Am J Physiol 1975;229:1116-1123.
5. Schuessler RB, Boineau JP, Wylds AC, et al: Effect of canine cardiac nerves on heart rate, rhythm, and pacemaker location. Am J Physiol 1986;250:H630-H644.
6. Kaumann AJ: Is there a third heart β-adrenoceptor? Trends Pharmacol Sci 1989; 10:316-320.
7. 2-adrenoceptors in the human heart: Properties, function, and alterations in chronic heart failure. Pharmacol Rev 1991;43:203-242.
8. Beau SL, Hand DE, Sehuessler RB, et al: Relative densities of muscarinic cholinergic and β-adrenergic receptors in the canine sinus node and their relation to sites of pacemaker activity. Circ Res 1995;77:957-963.
9. Murphree SS, Saffitz JE: Quantitative autoradiographic delineation of the distribution of β-adrenergic receptors in canine and feline left ventricular myocardium. Circ Res 1987;60:568-579.
10. Murphree SS, Saffitz JE: Delineation of the distribution of β-adrenergic receptor subtypes in canine myocardium. Circ Res 1988;63:117-125.
11. Saffitz JE, Beau SL: Adrenergic receptor autoradiography and in situ hybridization. Neuroprotocols 1994; 4:76-87.
12. Beau SL, Tolley TK, Saffitz JE: Heterogeneous transmural distribution of β-adrenergic receptor subtypes in failing human hearts. Circulation 1993;88:2501-2509.
13. 3H]opioid receptors in rat brain. Brain Res 1979;179:255-270.
14. Bleeker WK, Mackaay AJ, Masson-Pévet M, et al: Functional and morphological organization of the rabbit sinus node. Circ Res 1980;46:11-22.
15. Opthof T, de Jonge B, Mackaay AJ, et al: Functional and morphological organization of the guinea-pig sinoatrial node compared with the rabbit sinoatrial node. J Mol Cell Cardiol 1985;17:549-564.
16. Alings AMW, Abbas RF, Bouman LN: Age-related changes in structure and relative collagen content of the human and feline sinoatrial node. Eur Heart J 1995;16:1655-1667.
17. Muntz KH, Zhao M, Miller JC: Down-regulation of myocardial β-adrenergic receptors: Receptor subtype selectivity. Circ Res 1994;74:369-375.
18. Nedergaard OA, Abrahamsen J: Modulation of noradrenaline release by activation of prejunctional β-adrenoceptors in the cardiovascular system. Ann NY Acad Sci 1990;604:528-544.
19. Majewski H, McCulloch MW, Rand MJ, et al: Adrenaline activation of prejunctional β-adrenoceptors in guinea pig atria. Br J Pharmacol 1980;71:435-444.
20. Mackaay AJC, Opthof T, Bleeker WK, et al: Interaction of adrenaline and acetylcholine on cardiac pacemaker function. Functional inhomogeneity of the rabbit sinus node. J Pharmacol Exp Ther 1980;214:417-422.
21. Beau SL, Schuessler RB, Hand DE, et al: Heterogeneous distribution of muscarinic receptors in canine right atrium and sinoatrial node. (Abstract) PACE 1994;17(Pt II):792.
22. Hedberg A, Minneman KP, Molinoff PB: Differential distribution of beta-1 and beta-2 adrenergic receptors in cat and guinea-pig heart. J Pharmacol Exp Ther 1980;213:503-508.
23. 3H-dihy-droalprenolol binding. J Cardiovasc Pharmacol 1982;4: 34-43.
24. 2-adrenergic receptors contribute to catecholamine-stimulated shortening of action potential duration in dog atrial muscle. Proc Nat Acad Sci USA 1985;82:4521-4525.
25. Molenaar P, Canale E, Summers RJ: Autoradiographic localization of beta-1 and beta-2 adrenoceptors in guinea pig atrium and regions of the conducting system. J Pharmacol Exp Ther 1987;241:1048-1064.
26. 2-adrenoceptor subtypes in the rat sinoatrial node and stellate ganglia by quantitative autoradiography. Neurosci Lett 1989;96:35-41.
27. Muntz KH: Autoradiographic characterization of β-adrenergic receptor subtypes in the canine conduction system. Circ Res 1992;71:51-57.
28. 2-adrenergic receptor and angiotensin II receptor modulation of sympathetic neurotransmission in human atria. Circ Res 1994;74:434-440.
29. 2-adrenoceptors. Br J Pharmacol 1979;79:429-439.
30. Brown DA, Selyanko AA: Two components of muscarine-sensitive membrane current in rat sympathetic neurons. J Physiol (Lond) 1985;358:335-363.
31. Dörje F, Levey AI, Brann MR: Immunological detection of muscarinic receptor subtype proteins (m1-m5) in rabbit peripheral tissues. Mol Pharmacol 1991;40: 459-462.
32. Crick SJ, Wharton J, Sheppard MN, et al: Innervation of the human cardiac conduction system: A quantitative immunohistochemical and histochemical study. Circulation 1994;89:1697-1708.
33. Robberecht P, Delahaye M, Taton G, et al: The human heart beta-adrenergic receptors. I. Heterogeneity of the binding sites: Presence of 50% beta1- and 50% beta2-adrenergic receptors. Mol Pharmacol 1983;24:169-173.
34. Hedberg A, Kempf F, Josephson ME, et al: Coexistence of beta-1 and beta-2 adrenergic receptors in the human heart: Effects of treatment with receptor antagonists or calcium entry blockers. J Pharmacol Exp Ther 1985;234:561-568.
35. Stiles GL, Taylor S, Lefkowitz RJ: Human cardiac beta-adrenergic receptors: Subtype heterogeneity delineated by direct radioligand binding. Life Sci 1983;33:
36. 125I]iodocyanopindolol binding. Circ Res 1983;53:752-758.
37. Farmer JB, Levy GP, Marshall RJ: A comparison of the β-adrenoceptor stimulant properties of salbutamol, orciprenaline and soterenol with those of isoprenaline. J Pharm Pharmacol 1970;22:945-947.
38. Ablad B, Carlsson B, Carlsson E, et al: Cardiac effects of β-adrenergic receptor antagonists. Adv Cardiol 1974;12:290-302.
39. Carlsson E, Dahlof CG, Hedberg A, et al: Differentiation of cardiac chronotropic and inotropic effects of β-adrenoceptor agonists. Naunyn-Schmiedebergs Arch Pharmacol 1977;300:101-105.
40. 2-adrenoceptor-mediated positive inotropic effect possibly unrelated to cyclic AMP. Naunyn-Schmiedebergs Arch Pharmacol 1991;344:56-69.
41. 2-adrenoceptors in guinea-pig atria. J Pharm Pharmacol 1983;35:804-807.
42. Carlsson E, Hedberg A: Are cardiac effects of noradrenaline and adrenaline mediated by different β-adrenoceptors? Acta Physiol Scand Suppl 1976;440-447.
43. 2-adrenoceptor antagonist ICI 118,551 on exercise tachycardia and isoprenaline-induced β-adrenoceptor responses in man. Br J Clin Pharmacol 1985; 19: 619-630.
44. Johnsson G, Nyberg G, Solvell L: Influence of metoprolol and propranolol on hemodynamic effects induced by physical work and isoprenaline. Acta Pharmacol Toxicol 1975;36(Suppl V):69-75.
45. 2-adrenoceptors in the human heart. Circ Res 1989;65:546-553.
46. 2-adrenoceptors in human atrial myocardium. Circ Res 1990;66:1610-1623.
47. Kennedy MCS, Simpson WT: Human pharmacological and clinical studies on satbutamol: A specific β-adrenergic bronchodilator. Br J Dis Chest 1969;63:165-174.
48. Leitch AG, Clancy LJ, Costello JF, et al: Effect of intravenous infusion of salbutamol on ventilatory response to carbon dioxide and hypoxia and on heart rate and plasma potassium in normal men. Br Med J 1976; 1;365-367.
49. Briggs I, BoSmith RE, Heapy CG: Effects of Zeneca ZD7288 in comparison with alinidine and UL-FS 49 on guinea pig sinoatrial node and ventricular action potentials. J Cardiovasc Pharmacol 1994;24:380-387.
50. Kalman JM, Tonkin AM, Power JM: Specific effects of zatebradine on sinus node function: Suppression of automaticity, prolongation of sinoatrial conduction and pacemaker shift in the denervated canine heart. J Pharmacol Exp Ther 1995;272:85-93.
51. Boucher M, Chassaing C, Chapuy E: Cardiac electrophysiologic effects of alinidine, a specific bradycardic agent, in the conscious dog: Plasma concentration-response relations. J Cardiovasc Pharmacol 1995;25: 229-233.
52. Akahane K, Furukawa Y, Karasawa Y, et al: Muscarinic receptor subtypes mediating negative chrono-and inotropic responses in isolated, blood-perfused dog right atria. J Autonom Pharmacol 1990;10:39-48.
53. Larson EW, Pfenning MA, Richelson E: Selectivity of antimuscarinic compounds for muscarinic receptors of human brain and heart. Psychopharmacology 1991; 103:162-165.
54. Hartzell HC: Distribution of muscarinic acetylcholine receptors and presynaptic nerve terminals in amphibian heart. J Cell Biol 1980;86:6-20.
55. Wei JW, Sulakhe PV: Properties of the muscarinic cholinergic receptor in rat atrium. Naunyn-Schmiedebergs Arch Pharmacol 1979;309:259-269.
56. Fields JZ, Roeske WR, Morkin E, et al: Cardiac muscarinic cholinergic receptors. Biochemical identification and characterization. J Biol Chem 1978;253:3251-3258.